Search clinical trials for: Glatiramer Acetate
Total 3448 results
-
BiogenRecruitingMultiple SclerosisUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisGermany
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisGermany, Spain, Italy, France, United Kingdom
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveNetherlands
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
TakedaCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Multiple Sclerosis (RMS)United States
-
PfizerCompletedCrohn's DiseaseUnited States, Spain, Lebanon, Australia, Russian Federation, Korea, Republic of, Tunisia, Italy, Poland, Belgium, Austria, Germany, Saudi Arabia, Czechia, Hungary, Switzerland, Turkey, Slovakia, Ukraine, Georgia, Bosnia and Herzegovina and more
-
Mapi Pharma Ltd.Active, not recruiting
-
Genzyme, a Sanofi CompanyActive, not recruitingMultiple SclerosisPortugal, Turkey, Italy, Austria, Belgium, France, Netherlands, Poland, Russian Federation, United Kingdom
-
University of NebraskaTeva Branded Pharmaceutical Products R&D, Inc.WithdrawnMultiple SclerosisUnited States
-
Hadassah Medical OrganizationWeizmann Institute of ScienceCompletedHeart Failure | Inflammatory Response | Acute Decompensated Heart Failure | Cytokine StormIsrael
-
Al-Azhar UniversityBenha UniversityCompleted
-
TransgeneTerminatedColorectal Neoplasm | Digestive System NeoplasmFrance, Spain, Belgium
-
TransgeneTerminatedColorectal NeoplasmsFrance, United Kingdom
-
BiogenWithdrawn
-
University of Kansas Medical CenterActive, not recruitingBasal Cell Carcinoma | Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
IMPULS Endowment FundCompleted
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
Teva Pharmaceutical Industries, Ltd.CompletedAmyotrophic Lateral SclerosisBelgium, France, Germany, Israel, Italy, United Kingdom
-
National Cancer Institute, EgyptCompleted
-
OSF Healthcare SystemCompletedMultiple SclerosisUnited States
-
University of Colorado, DenverCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Poland, Romania, Russian Federation, South Africa, Ukraine, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
University of Medicine and Dentistry of New JerseyCompletedMultiple SclerosisUnited States
-
BiocadCompletedRelapsing-remitting Multiple Sclerosis
-
CinnagenCompletedRelapsing Multiple Sclerosis
-
University at BuffaloTeva Neuroscience, Inc.CompletedMultiple SclerosisUnited States
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
Montefiore Medical CenterRett Syndrome Research TrustCompletedRett SyndromeUnited States
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
University of Colorado, DenverRocky Mountain MS Research Group, LLCCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Teva Neuroscience, Inc.CompletedMultiple SclerosisUnited States
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceCompletedMultiple Sclerosis | Autoimmune DiseasesUnited States
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Rutgers, The State University of New JerseyCompletedMultiple SclerosisUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-Remitting | Relapsing-Remitting Multiple SclerosisCanada
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States